Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

Recruiting now

Conditions studied: Hematopoietic Stem Cell Transplant (HSCT)

In brief

To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.

Key facts

Study ID

NCT06702111

Run by

The University of Hong Kong

People needed

1000

Starts

2024-12-01

Expected to finish

2030-12-01

Last updated by the study team

2024-11-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients aged 18 years or older who received allogeneic hematopoietic stem cell transplantation (allo-HSCT).

You may not qualify if…

• participant who is unable to give informed consent in a prospective cohort.

Where it is running

• Department of Medicine, Queen Mary Hospital — Hong Kong, Hong Kong (enrolling)
• Queen Mary Hospital, Hong Kong — Hong Kong, Hong Kong (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.